Continuation Protocol for Obstructive Sleep Apnea (OSA)
Trial details
- Registry ID
- NCT06566820
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as AD109
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Continuation Protocol for Obstructive Sleep Apnea (OSA)NCT06566820 | Apnimed | Phase 3 | Enrolling by invitation | 2026-06-30Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |